US FDA Grants Expanded Approval Of IlluminOss Photodynamic Bone Stabilization System For Use In Femur And Tibia Fractures As Supplemental Fixation
IlluminOss Medical, a medical device company focused on minimally invasive orthopedic fracture repair, announced an expanded US Food and Drug Administration (US FDA 510k) clearance for its Photodynamic Bone Stabilization System. The new clearance allows IlluminOss to be used in femur and tibia fractures as supplemental fixation to US FDA-cleared fracture fixation systems."Femur and tibia fractures can be challenging in aging patients where osteoporotic bone often lacks the strength required for reliable fixation with traditional hardware systems," said Robert Rabiner, chief technology officer of IlluminOss. "This new clearance allows the surgical community to use the IlluminOss intramedullary implant as a supplement to these systems and help prevent construct failures by dramatically improving the holding power of screws and other hardware."
"Many lower limb fractures in the elderly, especially close to the knee joint, can be very difficult to achieve reliable stabilization due to poor bone quality," said Mike Mogul, chairman of IlluminOss. "As a minimally invasive means of supplementing hardware systems, IlluminOss provides substantial improvement in screw purchase and can optimize surgical outcomes. Surgeons can now securely affix their hardware anywhere along the length of the IlluminOss implant."
The IlluminOss System is a minimally invasive approach for fracture repair and stabilization through a patient-conforming intramedullary implant. The system utilizes a light-curable liquid monomer, contained within an expandable balloon, to create a patient-conforming, rigid implant within the bone canal. The IlluminOss technology has been in clinical use in Europe since 2010, and in the US since 2018, with over 4,000 procedures to date
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!